Jane Street Group, LLC Adverum Biotechnologies, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.5 - $2.33 $19,128 - $29,712	-12,752 Reduced 27.35%	33,877 $50,000
Q2 2023 Aug 14, 2023	SELL	$0.68 - $1.59 $31,289 - $73,162	-46,014 Reduced 49.67%	46,629 $74,000
Q1 2023 May 15, 2023	BUY	$0.62 - $0.85 $14,559 - $19,960	23,483 Added 33.95%	92,643 $66,000
Q4 2022 Feb 14, 2023	BUY	$0.54 - $10.3 $29,881 - $569,971	55,337 Added 400.33%	69,160 $40,000
Q3 2022 Nov 14, 2022	BUY	$0.96 - $9.68 $13,270 - $133,806	13,823 New	13,823 $13,000
Q1 2022 May 17, 2022	SELL	$1.23 - $1.95 $59,845 - $94,877	-48,655 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$1.74 - $2.4 $63,710 - $87,876	36,615 Added 304.11%	48,655 $86,000
Q3 2021 Nov 16, 2021	SELL	$2.08 - $3.6 $62,445 - $108,079	-30,022 Reduced 71.38%	12,040 $26,000
Q1 2021 May 18, 2021	SELL	$9.26 - $14.36 $108,480 - $168,227	-11,715 Reduced 21.78%	42,062 $415,000
Q4 2020 Feb 17, 2021	SELL	$9.84 - $14.26 $199,063 - $288,479	-20,230 Reduced 27.34%	53,777 $583,000
Q3 2020 Nov 17, 2020	BUY	$10.3 - $21.64 $15,820 - $33,239	1,536 Added 2.12%	74,007 $762,000
Q2 2020 Aug 17, 2020	BUY	$8.53 - $25.64 $483,088 - $1.45 Million	56,634 Added 357.61%	72,471 $1.51 Million
Q1 2020 May 15, 2020	SELL	$7.98 - $16.32 $44,719 - $91,457	-5,604 Reduced 26.14%	15,837 $155,000
Q4 2019 Feb 14, 2020	SELL	$5.12 - $12.22 $98,764 - $235,723	-19,290 Reduced 47.36%	21,441 $247,000
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $213,430 - $647,215	40,731 New	40,731 $222,000
Q2 2018 Aug 15, 2018	SELL	$5.3 - $6.9 $53,572 - $69,745	-10,108 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$3.65 - $7.95 $36,894 - $80,358	10,108 New	10,108 $59,000
Q4 2017 Feb 15, 2018	SELL	$2.85 - $3.95 $84,553 - $117,188	-29,668 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$2.45 - $3.65 $72,686 - $108,288	29,668	29,668 $108,000

Others Institutions Holding ADVM

# of Institutions

Shares Held

524K

Call Options Held

Put Options Held

Versant Venture Management, LLC San Francisco, CA

507K
Shares

$2.4 Million
9.32% of portfolio
Pinz Capital Management, LP New York, NY

15.7K
Shares

$74,418
0.03% of portfolio
American Portfolios Advisors Holbrook, NY

1.15K
Shares

$5,451
0.0% of portfolio

View Full List

About Adverum Biotechnologies, Inc.

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

More about ADVM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account